Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workersHelga Radner, Daniela Sieghart, Anselm Jorda, et al.
Rheumatology (Oxford, England)|November 18, 2021
Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritisPaul Studenic, Gregor Bond, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|June 10, 2026
Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapyTeresa Preglej, Anela Tosevska, Marie Brinkmann, et al.
Immunity|May 21, 2015
Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine SpecificityKiyoshi Hirahara, Atsushi Onodera, Alejandro V Villarino, et al.
Journal of Autoimmunity|May 27, 2017
MicroRNA-146a governs fibroblast activation and joint pathology in arthritisVictoria Saferding, Antonia Puchner, Eliana Goncalves-Alves, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases|June 21, 2023
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritisMaximilian Kugler, Mirjam Dellinger, Felix Kartnig, et al.
Clinical Immunology (Orlando, Fla.)|March 5, 2025
Autoantibody development is associated with clinical severity of COVID-19: A cohort studyMarie Brinkmann, Ludwig Traby, Manuel Kussmann, et al.
Annals of the Rheumatic Diseases|July 1, 2018
Non-classical monocytes as mediators of tissue destruction in arthritisAntonia Puchner, Victoria Saferding, Michael Bonelli, et al.
Pageof 9